Urinary trypsin inhibitor attenuates the development of neuropathic pain following spinal nerve ligation

[1]  J. Russell,et al.  An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor , 2014, Intensive Care Medicine.

[2]  K. Jung,et al.  The Effect of Urinary Trypsin Inhibitor Against Neuropathic Pain in Rat Models , 2013, The Korean Journal of Pain.

[3]  H. Muhammad,et al.  Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: a randomized double-blinded study , 2013, Korean journal of anesthesiology.

[4]  Shengshou Hu,et al.  Ulinastatin as a neuroprotective and anti‐inflammatory agent in infant piglets model undergoing surgery on hypothermic low‐flow cardiopulmonary bypass , 2013, Paediatric anaesthesia.

[5]  Y. Choi,et al.  Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass , 2012, Korean journal of anesthesiology.

[6]  Yuguo Chen,et al.  Effects of ulinastatin, a urinary trypsin inhibitor, on synaptic plasticity and spatial memory in a rat model of cerebral ischemia/reperfusion injury. , 2011, The Chinese journal of physiology.

[7]  Y. Li,et al.  Neuroprotection by Ulinastatin in Experimental Autoimmune Encephalomyelitis , 2011, Neurochemical Research.

[8]  Gila Moalem-Taylor,et al.  The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines , 2010, Journal of Neuroimmunology.

[9]  H. Cho,et al.  Interleukin‐6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK , 2010, European journal of pain.

[10]  H. Bae,et al.  Effect of ulinastatin on cytokine reaction during gastrectomy , 2010, Korean journal of anesthesiology.

[11]  C. Cahill,et al.  TNF-α and neuropathic pain - a review , 2010, Journal of Neuroinflammation.

[12]  A. Mauborgne,et al.  JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat , 2008, Journal of neurochemistry.

[13]  D. Basso,et al.  Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats , 2008, Experimental Neurology.

[14]  C. Sommer,et al.  Cytokine regulation in animal models of neuropathic pain and in human diseases , 2008, Neuroscience Letters.

[15]  K. Hayes,et al.  Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. , 2007, Archives of physical medicine and rehabilitation.

[16]  S. McMahon,et al.  Pathophysiology of Peripheral Neuropathic Pain: Immune Cells and Molecules , 2007, Anesthesia and analgesia.

[17]  L. Jinping,et al.  Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response. , 2007, The Journal of cardiovascular surgery.

[18]  D. Tracey,et al.  Immune and inflammatory mechanisms in neuropathic pain , 2006, Brain Research Reviews.

[19]  R. Myers,et al.  The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. , 2006, Drug discovery today.

[20]  C. Sommer,et al.  Intraneural injection of interleukin-1β and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain , 2005, Pain.

[21]  H. Lee,et al.  Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model , 2004, Neuroreport.

[22]  K. Chung,et al.  Segmental spinal nerve ligation model of neuropathic pain. , 2004, Methods in molecular medicine.

[23]  S. Rotshenker,et al.  The Cytokine Network of Wallerian Degeneration: Tumor Necrosis Factor-α, Interleukin-1α, and Interleukin-1β , 2002, The Journal of Neuroscience.

[24]  C. Sommer,et al.  Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice , 2001, Neuroscience Letters.

[25]  H. Tsujimoto,et al.  Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. , 2001, Shock.

[26]  C. Sommer,et al.  Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy , 1999, Neuroscience Letters.

[27]  A. Pertovaara,et al.  Spinal nerve ligation-induced neuropathy in the rat: sensory disorders and correlation between histology of the peripheral nerves , 1999, Pain.

[28]  A. Malhotra,et al.  Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[29]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[30]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.